Scientists have identified a potential new treatment strategy for Alzheimer’s disease using a combination of two existing ...
Efficacy and Safety of Aromatase Inhibitor Combined with Growth Hormone in Korean Boys with Idiopathic Short Stature: A ...
Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...
1The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. *Corresponding Author: Robert Wesolowski, Division of Medical Oncology, James Cancer Hospital and the Ohio State University, ...
A groundbreaking study shows that two repurposed cancer drugs, when combined, can correct complex brain cell dysfunction and restore memory in Alzheimer’s mouse models, offering hope for new ...
The objective response rate was 32%, which included 3 complete responses and 5 partial responses. The combination of metformin, letrozole, and abemaciclib appears safe and effective in patients with ...
MammaPrint (MP) determines distant metastatic risk and may improve patient selection for extended endocrine therapy (EET). This study examined MP in predicting extended letrozole therapy (ELT) benefit ...
A secondary analysis of the randomized controlled trial, IDEAL, confirms results from NSABP B-42 demonstrating MammaPrint is predictive of extended endocrine therapy benefit The published study, ...
A gene assay was predictive of response to extended letrozole therapy, identifying a subset of patients with low-risk breast cancer with improved outcomes. The 70-Gene MammaPrint (MP) assay predicted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback